Real-Life Efficacy of Palbociclib and Ribociclib in Advanced Breast Cancer
<b>Background:</b> Clinical trials in metastatic hormone receptor-positive (HR+) human epidermal growth factor receptor-2 (HER2)-negative patients have shown that cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors both increase response rates and provide survival benefits. The efficacy of these therap...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2025-03-01
|
| Colecção: | Current Oncology |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/1718-7729/32/3/161 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|